RNS Reach Story
Go to market news section Print
Zichain  -     

Advisory appointment

Released 10:00 16-Jul-2018

RNS Number : 7353U
Zichain
16 July 2018
 

 

 

 

 

 

Mr Ismail Malik Joins Zichain's Advisory Board

 

ZURICH, SWITZERLAND /JULY 16, 2018/ Zichain, a crypto finance company, is pleased to announce the appointment of Mr Ismail Malik to its Advisory Board as an international business development advisor.

Mr Malik has over 20 years of experience working in technology startups. He is currently the editor-in-chief of the ICOcrowd magazine, which is considered one of the world's most trusted publications primarily focused on initial coin offerings (ICO).

Mr Malik is also the founder and CEO of Blockchain Lab, a company specializing on research in blockchain technology. He is also rated among the top-100 most influential people in blockchain by Rise.global, a success tracking network .

Mr Malik is a recognized expert on tokenization and cryptocurrencies. He regularly speaks at blockchain events in East Asia.

Zichain combines the management team's extensive experience in the world of traditional finance with the cutting-edge technology. The company is developing four simple and safe products that will allow everyone to successfully invest into cryptocurrencies, track the performance of their investments, and receive the latest crypto market data.

Zichain's Advisory Board has been created to provide strategic guidance and valuable technical advice to the company's management team. It will also support Zichain in accessing new growth opportunities. Ismail Malik will be working together with Alexander Borodich, Jun Hao and Bogdan Fiedur, who joined the Advisory Board earlier this year.

Mr Ismail Malin commented: "I am excited to join Zichain's advisory board as I see an enormous potential of this company and believe that they can achieve a lot. Decentralized asset management has been lacking strong and confident players, capable of reaching the top of the game. I am certain that Zichain has what it takes to succeed and thrive. I am excited to work side by side with their team and other advisors and hope for a fruitful cooperation".

About Zichain

Zichain is a Switzerland-based blockchain finance company and a pioneer of the cryptocurrency index industry, having launched the world's first cryptocurrency indexation and analysis service in December 2017. Combining its extensive experience in the world of traditional finance with the cutting-edge technology, the company is developing a range of simple, safe and trusted products that allow everyone to successfully invest into cryptocurrencies, track the performance of their investments, and receive the latest crypto market data. Zichain is currently focused on the development of four key products: a unique and convenient platform for asset managers who wish to launch their own white label funds; a range of cryptocurrency index funds based on a family of crypto indices; a new infrastructure for the collection and analysis of industry news and market data; and a crypto-fiat exchange platform.

Zichain is a one-stop-shop for blockchain finance, with the mission of making it safe, orderly and accessible to everyone.

For further information, please, contact: media@zichain.io

 

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAGGURAMUPRURQ
Close


London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.

 


Advisory appointment - RNS